Updated cost comparison of home care subcutaneous versus outpatient intravenous trastuzumab for HER2-positive breast cancer in Singapore.
Saved in:
| Title: | Updated cost comparison of home care subcutaneous versus outpatient intravenous trastuzumab for HER2-positive breast cancer in Singapore. |
|---|---|
| Authors: | Ouyang Y; Health Services Research & Population Health, Duke-NUS Medical School, Singapore, Singapore., Ng YT; Office for Service Transformation, SingHealth, Singapore, Singapore., Hong WW; Office for Service Transformation, SingHealth, Singapore, Singapore., Graves N; Health Services Research & Population Health, Duke-NUS Medical School, Singapore 168582, Singapore. |
| Source: | Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2026 Mar 25; Vol. 18, pp. 17588359261421557. Date of Electronic Publication: 2026 Mar 25 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1758-8340 |
|---|---|
| DOI: | 10.1177/17588359261421557 |
